Abstract
Of all the chronic diseases, ischaemic heart disease (IHD) has been the object of the most detailed epidemiological study. We now have much information on possible causes of the disease and, with a reasonable degree of precision, can predict its future occurrence; that is, among an apparently healthy adult population we can distinguish those individuals with a high risk from those with a low risk of subsequently developing IHD. The highest risk group has more than 10 times the risk of the lowest risk group. This epidemiological knowledge has provided the basis for efforts to prevent IHD and to reduce its community burden. This chapter reviews the epidemiology and prevention of IHD, beginning with a consideration of the impact of the disease on the population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Armstrong, B. K., Mann, J. I. and Adelstein, A. M. (1975). Commodity consumption and ischaemic heart disease mortality, with special reference to dietary practices. J. Chronic Dis., 28, 455–469
Carlson, L. A., Bottiger, L. E. and Anfeldt, P. E. (1979). Risk factors for myocardial infarction in the Stockholm Prospective Study. Acta Med. Scand., 206, 351–360
Dawber, T. D. (1980). The Framingham Study. Cambridge, Mass.: Harvard University Press
Dwyer, J. and Hetzel, B. S. (1980). A comparison of trends of coronary heart disease mortality in Australia, USA and England and Wales with reference to three major risk factors - hypertension, smoking and diet. Int. J. Epidemiol. 9, 65–71
Epstein, F. H. (1971). Editorial. Atherosclerosis, 14, 1–2
Hjermann, I., Byrne, K.V., Holme, J. et al. (1981). Effect of diet and smoking intervention on the incidence of coronary heart disease: report from the Oslo Study Group of randomised trials in healthy men. Lancet, 2, 1303–1309
Hypertension Detection and Follow-Up Program Cooperative Group (1979). Five year findings of the hypertension detection and follow-up program. J. Am. Med. Assoc., 242, 2562–2571
Jenkins, C. D. (1976). Recent evidence supporting psychologic and social risk factors for coronary disease (first of two parts). N. Engl. J. Med., 294, 987–994 and 1033–1038
Kannell, W.B. and Castelli, W.P. (1979). Is the serum total cholesterol an anachronism? Lancet 2, 950–951
Keys, A. (1980). Seven Countries. Cambridge, Mass.: Harvard University Press
Lipid Research Clinics Program (1984). The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. J. Am. Med. Assoc., 251, 351–364
Management Committee (1980). The Australian Therapeutic Trial: mild hypertension. Lancet, 1, 1261–1267
Mann, J. I. and Marr, J. W. (1981). Coronary heart disease prevention: trials of diets to control hyperlipidaemia. In N. E. Miller and B. Lewis (eds) Lipoproteins, Atherosclerosis and Coronary Heart Disease. Amsterdam: Elsevier/North Holland, Biomedical Press
Marmot, M. G. (1984). Alcohol and coronary heart disease. Int. J. Epidemiol., 13, 160–167
Meade, T.W., Chakrabarti, R., Haines, A. P., North, W.R.S. and Stirling, Y. (1980). Haemostatic function and cardiovascular death: early results of a prospective study. Lancet, 1, 1050–1054
Morris, J.N., Marr, J. W. and Clayton, D.G. (1977). Diet and heart: a postscript. Br. Med. J., 2, 1307–1314
Morris, J.N., Pollard, R., Everitt, M.G. and Chave, S.P.W. (1980). Vigorous exercise in leisure time: protection against coronary heart disease. Lancet, 2, 1207–1210
Multiple Risk Factor Intervention Trial Research Group (1982). Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. J. Am. Med. Assoc., 248, 1465–1477
Oliver, M. F. (1981). Primary prevention of coronary heart disease: An appraisal of clinical trials of reducing raised plasma cholesterol. In: N. E. Miller and B. Lewis (eds.) Lipoproteins, Atherosclerosis and Coronary Heart Disease. (Amsterdam: Elsevier/North Holland, Biomedical Press)
Paffenbarger, R. S. and Hale, W.E. (1975). Work activity and coronary heart mortality. N. Engl. J. Med., 292, 545–550
Pelkonen, R., Nikkila, E.A., Koskinen, S., Plenttinen, K. and Sama, S. (1977). Association of serum lipids and obesity with cardiovascular mortality. Br. Med. J., 2, 1185–1187
Pocock, S.J., Shaper, A.G., Cook, D.G., Packham, R.F., Lacey, R.F., Powell, P.and Russell, P.F. (1980). British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br. Med. J., 280, 1243
Royal College of Physicians of London and British Cardiac Society. (1976). Prevention of coronary heart disease. (Report of a joint working party.) J. R. Coll. Physicians. Lond., 10, 1–63
Shekelle, R.B., Shrycock, A.M., Paul, O., Lepper, M., Stamler, J. et al. (1981). Diet, serum cholesterol and death from coronary heart disease: the Western Electric Study. N. Engl. J. Med., 304, 65–70
Stamler, R. and Stamler, J. (1979). Asymptomatic hyperglycaemic and coronary heart disease. J. Chronic Dis., 32, 683–691
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 MTP Press Limited
About this chapter
Cite this chapter
Marmot, M.G., Mann, J.I. (1987). Epidemiology of ischaemic heart disease. In: Fox, K.M. (eds) Ischaemic Heart Disease. Current Status of Clinical Cardiology, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3211-1_1
Download citation
DOI: https://doi.org/10.1007/978-94-009-3211-1_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7941-9
Online ISBN: 978-94-009-3211-1
eBook Packages: Springer Book Archive